FR308M - Nouvelle pyridyl-éthyl-guanidine utilisable en thérapeutique. - Google Patents

Nouvelle pyridyl-éthyl-guanidine utilisable en thérapeutique.

Info

Publication number
FR308M
FR308M FR836566A FR836566A FR308M FR 308 M FR308 M FR 308M FR 836566 A FR836566 A FR 836566A FR 836566 A FR836566 A FR 836566A FR 308 M FR308 M FR 308M
Authority
FR
France
Prior art keywords
guanidine
usable
therapy
ethyl
new pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR836566A
Other languages
English (en)
Inventor
Paul Mull Robert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR308M publication Critical patent/FR308M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR836566A 1959-05-15 1960-08-24 Nouvelle pyridyl-éthyl-guanidine utilisable en thérapeutique. Expired FR308M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US813335A US3036083A (en) 1959-05-15 1959-05-15 Certain 2-pyridyl lower alkyl guanidines

Publications (1)

Publication Number Publication Date
FR308M true FR308M (fr) 1961-03-03

Family

ID=25212082

Family Applications (2)

Application Number Title Priority Date Filing Date
FR827196A Expired FR1292948A (fr) 1959-05-15 1960-05-14 Procédé de préparation de pyridyl-(2)-alcoyl(inférieur)-guanidines, de leurs dérivés acylés, de leurs composés d'ammonium quaternaires et de leurs sels
FR836566A Expired FR308M (fr) 1959-05-15 1960-08-24 Nouvelle pyridyl-éthyl-guanidine utilisable en thérapeutique.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR827196A Expired FR1292948A (fr) 1959-05-15 1960-05-14 Procédé de préparation de pyridyl-(2)-alcoyl(inférieur)-guanidines, de leurs dérivés acylés, de leurs composés d'ammonium quaternaires et de leurs sels

Country Status (5)

Country Link
US (1) US3036083A (fr)
CH (1) CH392505A (fr)
DE (1) DE1420994A1 (fr)
FR (2) FR1292948A (fr)
GB (1) GB890602A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2195441A1 (fr) * 1972-08-08 1974-03-08 Knoll Ag

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147271A (en) * 1960-11-30 1964-09-01 Us Vitamin Pharm Corp Nu1-pyridylalkyl-n5-substituted biguanides
US3178443A (en) * 1963-04-01 1965-04-13 Ciba Geigy Corp N-(2-guandinoethyl)-n-(picolyl)-amines
US3352878A (en) * 1965-03-18 1967-11-14 Bristol Myers Co Certain pyridylmethyl guanidine derivatives
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
US3975530A (en) * 1972-09-05 1976-08-17 Smith Kline & French Laboratories Limited N-cyano-N'-heterocyclic-alkyl quanidine inhibitors of H2 histamine receptors
US3971786A (en) * 1972-09-05 1976-07-27 Smith Kline & French Laboratories Limited Pyridyl alkylguanidine compounds, composition therewith, and methods of inhibiting H-2 histamine receptors
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
US4782946A (en) * 1987-09-17 1988-11-08 Allergan, Inc. Soft contact lens hydration device and kit

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE579145C (de) * 1932-03-18 1933-06-21 Chem Fab Von Heyden Akt Ges Verfahren zur Darstellung von Guanidinabkoemmlingen der Pyridinreihe

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2195441A1 (fr) * 1972-08-08 1974-03-08 Knoll Ag

Also Published As

Publication number Publication date
CH392505A (de) 1965-05-31
US3036083A (en) 1962-05-22
FR1292948A (fr) 1962-05-11
DE1420994A1 (de) 1968-10-31
GB890602A (en) 1962-03-07

Similar Documents

Publication Publication Date Title
FR308M (fr) Nouvelle pyridyl-éthyl-guanidine utilisable en thérapeutique.
FR302M (fr) Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique.
BE596003A (fr) Amino-hydroxy-nitriles.
FR1898M (fr) Nouvelle substance utilisable en thérapeutique.
FR164M (fr) Nouvelle hydrazine utilisable en thérapeutique.
FR353M (fr) Nouvelle quinoléine utilisable en thérapeutique.
FR310M (fr) Nouvelle aza-hexylene-imino-éthyl-guanidine utilisable en thérapeutique.
FR350M (fr) Nouvel antibiotique lankavamycine utilisable en thérapeutique.
FR221M (fr) Nouvelle guanidine utilisable en thérapeutique.
FR347M (fr) Nouvelle 1,3-dihydroxy-2-amino-nonadec-4-yne utilisable en thérapeutique.
OA01426A (fr) Synchro-machines perfectionnées.
FR303M (fr) Nouvelle guanidine utilisable en thérapeutique.
DK103424C (da) Høvender.
FR222M (fr) Nouvelle 2,5-bis-éthylene-imino-3,6-bis-acylamino-p-benzoquinone utilisable en thérapeutique.
DK120015B (da) Fluidistor.
BE595070A (fr) Plansichter.
FR163M (fr) Nouvelle phénoxy-éthylamine utilisable en thérapeutique.
BE596272A (fr) Nouvelle substance utilisable en thérapeutique.
FR352M (fr) Nouvel antibiotique ferrimycine utilisable en thérapeutique.
FR351M (fr) Nouvel antibiotique lankavacidine utilisable en thérapeutique.
FR348M (fr) Nouveau glucofuranoside 3,5,6-substitué utilisable en thérapeutique.
FR115M (fr) Nouveau sulfonamide utilisable en thérapeutique.
GR19832B (el) Ηλεκτροδιον χρησιμευον εις την ληψιν ηλεκτροεγκεφαλογραφηματος.
FR1494M (fr) Nouvelle création en thérapeutique.
GR20154B (el) Πρυσσομενη τραπεζα.